Lundbeck
Business & Industry
- Sanofi and Cheplapharm to create new strategic partnership in mature medicines
- AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries
- Pfizer and Valneva's Lyme disease vaccine candidate Marketing Authorization Application validated by European Medicines Agency
- Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
- Sanofi Foundation opens new chapter centered on future generations
Research & Development
- Child cancer groups call for concerted action
- Experimental study points to systemic sclerosis treatment
- Protein build-up may shape cancer drug response
- Hidden immune cells in the lung could lead to better flu vaccines
- Novel drug shows promise in an early phase trial in heart failure
- Cholesterol-lowering medication reduces heart attack and stroke risk in older people by 30%
- Scientists decode gene circuits of human immunity, fueling new era of disease research
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA approves first in class targeted therapy for metastatic pancreatic cancer
- FDA approves first drug of its kind for polycythemia vera, a rare blood disorder
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B